About Joel Wernick
Form D filings for SignalRX Pharmaceuticals in 2023 list Joel Wernick as director.
Joel Wernick first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Joel Wernick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joel Wernick works with at each company, as listed on that company's latest Form D.
SignalRX Pharmaceuticals, Inc · Form D, May 3, 2023
GM
Guillermo Morales
Director
MW
Matthew Williams
Director and Chief Executive Officer